Emmanuel Dejean is a distinguished Chief Executive Officer of the biotechnology industry with extensive experience in Innovation Management, Patent Law, Biotechnology, Start-ups, and Research and Development (R&D). He has professional expertise in physical chemistry, bioelectrochemistry, and holds a PhD from the Université des Sciences et Techniques du Languedoc. Dejean is also the CEO and Chairman, Co-founder of CALIXAR, and has previously worked for reputable organizations such as EMROD Consulting, ALMA consulting group, ACIES Consulting Group, IFTH, and CNRS.

Dejean's career journey involves a wealth of experience in biotechnology, from working on projects as a project leader at CNRS to his present role as the CEO and chairman of CALIXAR. His knowledge in patent law and research and development has been crucial to his success in the industry, which has led to working with various reputable consulting groups. Dejean's expertise in biotechnology, physical chemistry, and bioelectrochemical areas continues to grow as he remains dedicated to making positive changes in the biotechnology industry.